A new way to regulate protein levels and functions could be the answer to treating devastating neurological conditions
New details learned about a key cellular protein could lead to treatments for neurodegenerative diseases, such as Parkinson’s, Huntington’s, Alzheimer’s, and amyotrophic lateral sclerosis (ALS).
At their root, these disorders are triggered by misbehaving proteins in the brain. The proteins misfold and accumulate in neurons, inflicting damage and eventually killing the cells. In a new study, researchers in the laboratory of Steven Finkbeiner, MD, PhD, at the Gladstone Institutes used a different protein, Nrf2, to restore levels of the disease-causing proteins to a normal, healthy range, thereby preventing cell death.
The researchers tested Nrf2 in two models of Parkinson’s disease: cells with mutations in the proteins LRRK2 and a-synuclein. By activating Nrf2, the researchers turned on several “house-cleaning” mechanisms in the cell to remove excess LRRK2 and a-synuclein.
“Nrf2 coordinates a whole program of gene expression, but we didn’t know how important it was for regulating protein levels until now,” explained first author Gaia Skibinski, PhD, a staff research scientist at Gladstone. “Overexpressing Nrf2 in cellular models of Parkinson’s disease resulted in a huge effect. In fact, it protects cells against the disease better than anything else we’ve found.”
In the study, published in the Proceedings of the National Academy of Sciences, the scientists used both rat neurons and human neurons created from induced pluripotent stem cells. They then programmed the neurons to express Nrf2 and either mutant LRRK2 or a-synuclein. Using a one-of-a-kind robotic microscope developed by the Finkbeiner laboratory, the researchers tagged and tracked individual neurons over time to monitor their protein levels and overall health. They took thousands of images of the cells over the course of a week, measuring the development and demise of each one.
The scientists discovered that Nrf2 worked in different ways to help remove either mutant LRRK2 or a-synuclein from the cells. For mutant LRRK2, Nrf2 drove the protein to gather into incidental clumps that can remain in the cell without damaging it. For a-synuclein, Nrf2 accelerated the breakdown and clearance of the protein, reducing its levels in the cell.
“I am very enthusiastic about this strategy for treating neurodegenerative diseases,” said Finkbeiner, a senior investigator at Gladstone and senior author on the paper. “We’ve tested Nrf2 in models of Huntington’s disease, Parkinson’s disease, and ALS, and it is the most protective thing we’ve ever found. Based on the magnitude and the breadth of the effect, we really want to understand Nrf2 and its role in protein regulation better.”
The scientists say that Nrf2 itself may be difficult to target with a drug because it is involved in so many cellular processes, so they are now focusing on some of its downstream effects. They hope to identify other players in the protein regulation pathway that interact with Nrf2 to improve cell health and that may be easier to drug.
Learn more: Single Protein May Hold Secret to Treating Parkinson’s Disease and More
[osd_subscribe categories=’neurodegenerative-diseases-2′ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “NEURODEGENERATIVE DISEASES”‘]
Receive an email update when we add a new NEURODEGENERATIVE DISEASESÂ article.
The Latest on: Regulate protein levels and functions
[google_news title=”” keyword=”regulate protein levels and functions” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Regulate protein levels and functions
- Cytokine Release Syndrome: What to Knowon May 2, 2024 at 12:25 pm
Cytokine release syndrome (CRS) occurs when the immune system responds to infection or immunotherapy drugs more aggressively than it should. Learn more here.
- Study elucidates how energy metabolism is regulated at cellular levelon May 2, 2024 at 12:06 pm
An article published in The FASEB Journal describes a Brazilian study analyzing the correlation between two key energy metabolism regulation processes: the absorption and release of calcium ions by ...
- Small molecule shows early-stage promise for repairing myelin sheath damageon May 2, 2024 at 9:35 am
When treated with a novel protein function inhibitor called ESI1, mice that mimic the symptoms of multiple sclerosis (MS) and lab-prepared human brain cells both demonstrated the ability to regenerate ...
- Novel Blood Biomarkers Show Potential for Early Liver Cancer Diagnosison May 1, 2024 at 5:00 pm
1 Several tools have been evaluated for diagnosing HCC, including liver ultrasonography, alpha-fetoprotein (AFP) levels ... proteins, to determine whether protein biomarkers in blood could inform ...
- Regulating Cholesterol Levels Could Improve Cancer Immunotherapies, Study Findson April 30, 2024 at 5:00 pm
"We’ve identified a new mechanism that can regulate a crucial immune pathway ... By manipulating cholesterol levels, the researchers were able to improve the function of the STING protein, thereby ...
- Plant science research paves the way for deeper understanding of how the plant immune system functionson April 29, 2024 at 1:40 pm
Smith, Ph.D. at the Danforth Plant Science Center and the University of Tennessee, Knoxville, are conducting pioneering work to discover how plants transmit information, important molecules, and ...
- Glycogen Control Reviews - Does It Really Work?on April 29, 2024 at 5:45 am
Generally, the company advises taking one Glycogen Control pill a day. With a full glass of water or your favorite beverage, it is ideal to take the capsule. While you can take it whenever is most ...
- 13 Simple Steps For Career-Focused Women To Lose Weight Without Giving Up Their Favorite Foodson April 27, 2024 at 5:00 pm
Portion control is not just about eating less; it’s about eating smart. By choosing smaller portions, you can enjoy a variety of foods without the guilt. A balanced meal should have a healthy mix of ...
- Keto diet may help lower cholesterol, toxic proteins in Alzheimer’s diseaseon April 23, 2024 at 10:31 am
New research in rat models of Alzheimer's disease suggests that a ketogenic diet may help lower blood lipids and tau protein levels, improving Alzheimer's-like symptoms.
via Bing News